Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2473069 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Complement Factor H (CFH) antibody
- Antibody type
- Monoclonal
- Description
- Purified
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- OX-24
- Vial size
- 0.2 mg
Submitted references Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration.
Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisited.
Truncated forms of human complement factor H.
Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H.
Kelly U, Yu L, Kumar P, Ding JD, Jiang H, Hageman GS, Arshavsky VY, Frank MM, Hauser MA, Rickman CB
Journal of immunology (Baltimore, Md. : 1950) 2010 Nov 1;185(9):5486-94
Journal of immunology (Baltimore, Md. : 1950) 2010 Nov 1;185(9):5486-94
Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisited.
Johnson SA, Williams JM, Hakobyan S, Richards A, Perkins SJ, Marchbank KJ, Goodship TH, Morgan BP, Taylor CM, Savage CO
Molecular immunology 2010 Apr;47(7-8):1585-91
Molecular immunology 2010 Apr;47(7-8):1585-91
Truncated forms of human complement factor H.
Fontaine M, Demares MJ, Koistinen V, Day AJ, Davrinche C, Sim RB, Ripoche J
The Biochemical journal 1989 Mar 15;258(3):927-30
The Biochemical journal 1989 Mar 15;258(3):927-30
Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H.
Alsenz J, Schulz TF, Lambris JD, Sim RB, Dierich MP
The Biochemical journal 1985 Dec 15;232(3):841-50
The Biochemical journal 1985 Dec 15;232(3):841-50
No comments: Submit comment
No validations: Submit validation data